Stay updated on Nivolumab Combinations in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.3%
    Check dated 2026-10-25T15:51:29.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T22:24:58.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T22:20:55.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page shows Revision: v3.7.0 replacing the previous v3.6.6, indicating an update to the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-09-20T20:10:33.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.5 to v3.6.6, indicating a new software version. This update does not affect the study data or the information presented on the page.
    Difference
    0.0%
    Check dated 2026-08-30T15:16:58.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.5) was added to the study’s record history. The older revision (v3.6.4) and the References section were removed from the history.
    Difference
    0.3%
    Check dated 2026-08-16T11:23:07.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.